Dr. Mani Sharma Publishes Research on Green Catalysis
Anurag University proudly congratulates Dr. Mani Sharma, Assistant Professor, Department of Pharmaceutics, School of Pharmacy, on the publication of his research article titled “Tailored Catalysis as a Cornerstone for Advancing Green Chemistry: A Call for Sustainable Innovation.” This achievement highlights his commitment to research and the pursuit of sustainable scientific solutions.
The article explores the role of tailored catalysis in advancing green chemistry, emphasizing the importance of innovative catalytic approaches in supporting more sustainable chemical processes. The research contributes to ongoing academic discussions on environmentally responsible innovation and the development of greener approaches in chemistry.
The article has been published in Current Organocatalysis, by Bentham Science Publishers. According to the details provided, the journal is Scopus-indexed, with an Impact Factor of 1.1, an H-index of 19, and a Q4 quartile ranking. Anurag University congratulates Dr. Sharma on this publication and wishes him continued success in his research endeavours.
Written By
By AU Media Team
More Stories You Might Like
Women’s Throwball Team Claims Runner-Up Position
Anurag University’s Women’s Throwball Team secured second place at AURA 2026, a national-level inter-engineering college fest hosted by CBIT, showcasing outstanding teamwork, determination, and competitive spirit.
Exploring Novel Approaches to Cancer Treatment
Dr. Syeda Jabeen Fatima, Assistant Professor in the Department of Pharmacy at Anurag University, has published research on novel chalcone–hydrazone derivatives as tubulin polymerization inhibitors in the International Journal of Drug Delivery Technology, a Scopus-indexed Q3 journal.
Advancing Research in Targeted Drug Formulations
B. Nirosha, Assistant Professor at the School of Pharmacy, Anurag University, has been awarded a Ph.D. for her research on polymer-based nanoparticulate drug formulations to enhance apoptotic potential in hormone receptor-positive breast cancer.
